Document Classification

Section Type: RESULTS

Text: Comparing the DEB vs. the DES the 9-month results (follow-up DEB 39/45 [86. 7 %], DES 36/39 [92. 3 %]) are statistically not different at the 0. 05 level for the primary endpoint of in-segment (0. 37 0. 59 mm vs. 0. 35 0. 63 mm) and in-stent (0. 51 0. 61 mm vs. 0. 53 0. 67 mm) late lumen loss, overall and cardiac deaths (2/45 [4. 4 %] and 3/45 [6. 7 %] vs. 0), target lesion revascularisation (3/45 [8. 9 %] vs. 4/39 [10. 3 %]), the total MACE rate (6/45 [13. 3 %] vs. 6/39 [15. 4 %]), and the event free survival after 10. 2 3. 8 months (Kaplan-Meier analysis, p < 0. 80, log rank test).